iShares iBonds Dec 2037 Term EUR Corporate UCITS ETF EUR (Acc)
Bloomberg MSCI December 2037 Maturity EUR Corporate ESG Screened
- ISIN
- IE0007SRI1C7
- Issuer
- iShares
- TER
- 0.12%
- Latest closing price
- 4.92 EUR · Source: Yahoo
- Fund Size
- €27 m As of: Nov 13, 2026
- Domicile
- Ireland
- Distribution Policy
- Accumulating
- Replication Method
- Physical
- Base Currency
- EUR
- WKN / Ticker
- A424JP / IB37
Closing price of the trading day shown, not a real-time price. Prices can differ by exchange and trading currency.
Data availability
Data is available for 5 of 5 areas for this fund.
- Master data (TER, index, size): As of: Nov 13, 2026
- Closing price: As of: Nov 20, 2026
- Price history (at least 20 prices): As of: Nov 20, 2026
- Holdings: As of: Nov 13, 2026
- Risk figures: As of: Nov 22, 2026
Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.
At a glance
Data as ofiShares iBonds Dec 2037 Term EUR Corporate UCITS ETF EUR (Acc) (ISIN IE0007SRI1C7) is a fund from iShares (fund type: ETF). Benchmark index: Bloomberg MSCI December 2037 Maturity EUR Corporate ESG Screened. Its ongoing charges (TER) are 0.12% per year. The fund size is €27 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland. Latest closing price: 4.92 EUR (as of Nov 20, 2026).
- Launch date 15.05.2026 (less than 1 year)
- Number of Holdings 44
- Strategy Passive (index tracking)
- Base Currency EUR
- Currency hedging No
- Distribution Policy Accumulating
- Replication Method Physical
- Securities lending No
- Domicile IE
- UCITS Compliant Yes
Price development
Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.
Risk figures
- Volatility
- 5.24 %
- Annualised range of fluctuation of daily price changes.
- Max Drawdown
- −1.27 %
- Largest price decline from a peak to the following low within the period.
- Sharpe Ratio
- 1.36
- Return above the risk-free rate relative to volatility. Of limited significance over at most 12 months.
Own calculation from 34 daily closing prices from Oct 6, 2026 to Nov 20, 2026 (at most 12 months), calculated on Nov 22, 2026. Sharpe ratio uses an assumed risk-free rate of 2 % p.a.
The price history covers less than 12 months. The figures are therefore of limited significance and not comparable with annual figures from other sources.
The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.
Documents
We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.
Search documents at iSharesTracking difference and tracking error
We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.
What does the fund invest in?
As of 10.09.2026 · Source: justETF / etfdbSector Breakdown
-
Industrials 19.5%
-
Consumer staples 15.3%
-
Financials 13.5%
-
Health care 13.2%
-
Utilities 11.7%
-
Telecommunication 10.7%
-
Consumer discretionary 7.4%
-
Basic materials 5.0%
-
Technology 3.1%
-
Government bonds 0.7%
-
Other 0.1%
Country Breakdown
-
United States 37.8%
-
France 17.2%
-
Germany 13.8%
-
United Kingdom 12.7%
-
Japan 5.8%
-
Netherlands 5.3%
-
Denmark 3.0%
-
Switzerland 2.1%
-
Australia 1.8%
-
Ireland 0.6%
-
Cash 0.0%
Holdings
Showing 10 holdings that together make up 29.6 % of fund assets. (out of 44 holdings in total).
| # | Name | Weight |
|---|---|---|
| 1 | NTT Finance Corporation, 4.091% 16jul2037, EUR | 3.07 % |
| 2 | Novo Nordisk, 3.625% 27may2037, EUR | 3.05 % |
| 3 | Schneider Electric, 3.624% 2sep2037, EUR (43) | 3.02 % |
| 4 | Mercedes-Benz Group, 2.125% 3jul2037, EUR (80) | 3.02 % |
| 5 | Orange, 3.75% 4sep2037, EUR (179) | 2.98 % |
| 6 | Verizon Communications, 3.75% 6aug2037, EUR | 2.98 % |
| 7 | Alphabet, 3.375% 6may2037, EUR | 2.97 % |
| 8 | Bouygues, 3.25% 30jun2037, EUR | 2.95 % |
| 9 | JR-East, 3.727% 2sep2037, EUR (12) | 2.77 % |
| 10 | Merck & Co, 3.5% 30may2037, EUR | 2.76 % |
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.
Alternatives on the same index
Other ETFs tracking the Bloomberg MSCI December 2037 Maturity EUR Corporate ESG Screened – cheapest first.| Name | TER | Fund Volume | Distribution |
|---|---|---|---|
| iShares iBonds Dec 2037 Term EUR Corporate UCITS ETF EUR (Acc) This fund | 0.12% | €27 m | Accumulating |
| iShares iBonds Dec 2037 Term EUR Corporate UCITS ETF EUR (Dist) New launch | 0.12% | €6.0 m | Distributing |
Frequently asked questions about the iShares iBonds Dec 2037 Term EUR Corporate UCITS ETF EUR (Acc)
All information without guarantee. It is provided for information purposes only and does not constitute investment advice.